Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$650,091
+$350,246 QoQ
Shares Held
542
+66.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#3,523
of 4,605 holders
Holding Since
Dec 2021
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FSB PREMIER WEALTH MANAGEMENT, INC. holds $7,731,577 across 11 Drug Manufacturers - General names. LLY ranks #5 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
13,534 | $2,121,048 | |
| 2 | SNY |
Sanofi
|
28,290 | $1,206,851 | |
| 3 | JNJ |
Johnson & Johnson
|
3,956 | $1,004,705 | |
| 4 | AMGN |
Amgen Inc
|
2,273 | $823,098 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
542 | $650,091 | |
| 6 | ABBV |
AbbVie Inc.
|
1,978 | $497,743 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,061 | $349,234 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,238 | $287,583 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $650,091 | 542 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $299,845 | 326 | Shares | Sole | 2026-05-13 | |
| 2021-12-31 | $30,936 | 112 | Shares | Sole | 2022-02-03 | |
| No filing history on record for this holder in this stock. | ||||||